Journal
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT
Volume 7, Issue -, Pages 1-10Publisher
CELL PRESS
DOI: 10.1016/j.omtm.2017.08.004
Keywords
-
Categories
Funding
- CNPq
- FAPESP [2012/18617-1, 2015/17174-7]
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [12/18617-1] Funding Source: FAPESP
Ask authors/readers for more resources
The delivery of antigens as DNA vaccines is an efficient alternative to induce immune responses against antigens, which are difficult to produce in recombinant form. However, the delivery of naked DNA is ineffective or relies on sophisticated ballistic devices. Here, we show a combination of liposome application and naked DNA vaccine that successfully overcomes these problems. Upon entrapment of plasmids encoding different antigens in cationic particles, transfection efficiencies similar to commercial kits were achieved in in vitro cell cultures. The liposome-based approach provided strong humoral responses against three malarial antigens, namely the Circumsporozoite protein and the C terminus of merozoite surface protein 1 from Plasmodium vivax (titers 10(4) or 10(3)-10(4), respectively) and P. falciparum Rhoptry antigen 5 from Plasmodium falciparum (titers 10(3)-10(4)). When employed in P. falciparum growth-inhibition assays, antibodies demonstrated consistent reinvasion-blocking activities that were dose dependent. Liposome-formulated DNA vaccines may prove useful when targets cannot be produced as recombinant proteins and when conformation-dependent and highly specific antibodies are mandatory.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available